Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-29T02:05:18.809Z Has data issue: false hasContentIssue false

Cholecystokinin Hypothesis of Tourette Syndrome

Published online by Cambridge University Press:  18 September 2015

Henrik K. Kulmala
Affiliation:
Department of Medical & Surgical Neurology, Texas Tech University Health Sciences Center, Lubbock, Texas 794
Sakkubai Naidu
Affiliation:
John F. Kennedy Institu, Baltimore
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Copyright
Copyright © Canadian Neurological Sciences Federation 1984

References

Friedhoff, AJ (1982) Receptor maturation in pathogenesis and treatment of Tourette Syndrome. In Friedhoff, A.J., Chase, T.N., eds., Gilles de la Tourette Synbdrome. Advances in Neurology, Vol. 35. Raven Press, New York, pp. 133140.Google Scholar
Fuxe, K, Agnati, LF, Köhler, C, Kuonen, D, Ögren, S-O, Andersson, K, Hokfelt, T (1981) Characterization of normal and supersensitive dopamine receptors: Effects of ergot drugs and neuropeptides. J Neural Trans 51: 337.CrossRefGoogle ScholarPubMed
Meyer, DK, Beinfeld, MC, Oertel, WH, Brownstein, MJ (1982) Origin of the cholecystokinin-containing fibers in the rat caudatoputamen. Science 215: 187188.CrossRefGoogle ScholarPubMed
Nair, NPV, Bloom, DM, Nestoros, JN, Schwartz, G (1983) Therapeutic efficacy of cholecystokinin in neuroleptic-resistant schizophrenic subjects. Psychopharmacol Bull 19: 134136.Google Scholar
Van Ree, JM, Gaffori, O, DeWied, D (1983) In rats, the behavioral profile of CCK-8 related peptides resembles that of antipsychotic agents. Eur J Pharmacol 93: 6378.CrossRefGoogle ScholarPubMed